Back to Journals » Clinical Ophthalmology » Volume 15

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Total article views   HTML views PDF downloads Totals
5,742 Dovepress* 5,006+ 703 5,709
PubMed Central* 736 253 989
Totals 5,742 956 6,698
*Since 12 January 2021

View citations on PubMed and Google Scholar